🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Childhood Medulloblastoma

Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback NCT07830134NA1 site📍 Memphis St. Jude Children's Research Hospital · Tests: rt fMRI Neurofeedback (DLPFC), rt fMRI Neurofeedback (PAC) Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma NCT05535166Phase 210 sites📍 Palo Alto📍 Orlando📍 Tampa St. Jude Children's Research Hospital · Tests: Surgical resection, Ommaya/VPS, Methotrexate, Cisplatin, Vincristine Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease NCT07346157Phase 1, Phase 23 sites📍 San Francisco📍 Washington D.C.📍 Seattle Sabine Mueller, MD, PhD · Tests: Liothyronine (L-T3), Bevacizumab, Irinotecan, Temozolomide (TMZ) Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study NCT07242963n/a2 sites📍 Houston📍 Houston Mohammad H. Abu Arja A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss NCT05382338Phase 3111 sites📍 Birmingham📍 Mobile📍 Phoenix Children's Oncology Group · Tests: Audiometric Test, Auditory Brainstem Response, Biospecimen Collection, Cisplatin, Cyclophosphamide International HIT-MED Registry (I-HIT-MED) NCT02417324n/a57 sites📍 Aachen📍 Augsburg📍 Berlin Universitätsklinikum Hamburg-Eppendorf Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation NCT06942039EARLY Phase 112 sites📍 Calgary📍 Vancouver📍 Winnipeg C17 Council · Tests: Cytarabine IT, hydrocortisone, Cisplatin, Vincristine, Etoposide Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors NCT04185038Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma NCT06959979EARLY Phase 11 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: CDK4/6 Inhibitor (Palbociclib, Ribociclib, Abemaciclib) Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour NCT05230758Phase 320 sites📍 New Lambton Heights📍 Westmead📍 Adelaide Donald Mabbott · Tests: Metformin hydrochloride (HCl) 500mg tablet, Placebo HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors NCT03911388Phase 13 sites📍 Birmingham📍 St Louis📍 Houston M.D. Anderson Cancer Center · Tests: G207 Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer NCT05106296Phase 11 site📍 Augusta Theodore S. Johnson · Tests: Indoximod, Ibrutinib, Cyclophosphamide, Etoposide, Ibrutinib Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT) NCT06193759Phase 11 site📍 Washington D.C. Children's National Research Institute · Tests: Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized… Medulloblastoma Online Video-based Exercise Pilot Study NCT06898684NA2 sites📍 München📍 Gothenburg Aron Onerup · Tests: Exercise B7-H3.CD28Z.CART in CNS Neoplasms NCT07390539Phase 12 sites📍 Boston📍 Boston Robbie Majzner · Tests: B7-H3.CD28Z.CART, Fludarabine, Cyclophosphamide GD2-CAR T Cells for Pediatric Brain Tumours NCT05298995Phase 11 site📍 Roma Bambino Gesù Hospital and Research Institute · Tests: GD2-CART01 (iC9-GD2-CAR T-cells) Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma NCT05057702NA9 sites📍 Los Angeles📍 San Diego📍 San Francisco University of California, San Francisco · Tests: Specialized Tumor Board Treatment Plan, Combinations GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults NCT07087002Phase 11 site📍 Palo Alto Stanford University · Tests: GPC2-CAR T cells, Fludarabine, Cyclophosphamide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy